# SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

> **NCT01811277** · PHASE2 · UNKNOWN · sponsor: **Peking University** · enrollment: 40 (estimated)

## Conditions studied

- Biliary Tract Cancer
- Periampullary Adenocarcinoma
- Pancreatic Cancer

## Interventions

- **DRUG:** SOX sequential S-1

## Key facts

- **NCT ID:** NCT01811277
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811277, "SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01811277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*